This brand name is authorized in Austria, Estonia, Finland, Croatia, Ireland, Italy, Lithuania, Netherlands, Poland, United Kingdom, United States
The drug SCENESSE contains one active pharmaceutical ingredient (API):
1
Afamelanotide
UNII QW68W3J66U - AFAMELANOTIDE
|
Afamelanotide is a synthetic tridecapeptide and a structural analogue of α-melanocyte stimulating hormone (α-MSH). Afamelanotide is a melanocortin receptor agonist and binds predominantly to the melanocortin-1 receptor (MC1R). Afamelanotide is thought to mimic the endogenous compound’s pharmacological activity by activating the synthesis of eumelanin mediated by the MC1R receptor. Eumelanin contributes to photoprotection through different mechanisms. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
SCENESSE Implant | European Medicines Agency (EU) | MPI, EU: SmPC |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
D02BB02 | D Dermatologicals → D02 Emollients and protectives → D02B Protectives against UV-radiation → D02BB Protectives against UV-radiation for systemic use | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: EE | Ravimiamet | Identifier(s): 1673928 |
Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 393360 |
Country: IT | Agenzia del Farmaco | Identifier(s): 043798014 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1075287 |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 134384 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100334761 |
Country: US | FDA, National Drug Code | Identifier(s): 73372-0116 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.